Sanofi Genzyme:企業の戦略・SWOT・財務分析

◆英語タイトル:Sanofi Genzyme - Strategy, SWOT and Corporate Finance Report
◆商品コード:SWOT20MY3703
◆発行会社(調査会社):MarketLine
◆発行日:2019年12月
◆ページ数:45
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥18,200見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥36,400見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥54,600見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Sanofi Genzyme – Strategy, SWOT and Corporate Finance Report
Summary

Sanofi Genzyme – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Sanofi Genzyme (Genzyme), a specialty care global business unit of Sanofi provides treatments with a focus on rare diseases, multiple sclerosis, immunology, and oncology. The major products of the company include Aldurazyme, Aubagio, Caprelsa tablets, Cerdelga capsules, Cerezyme, Clolar, Dupixent injection, Elitek, Eloxatin, Fabrazyme, Jevtana, Kevzara injection, Lemtrada, Lumizyme, Mozobil injection, Taxotere injection concentrate, Thymoglobulin, Thyrogen and ZALTRAP injection for intravenous infusion. The company also addresses the unmet needs in immune diseases including atopic dermatitis, rheumatoid arthritis, asthma, nasal polyposis, and eosinophilic esophagitis. The company primarily operates in the Americas and Europe. Genzyme is headquartered in Cambridge, Massachusetts, the US.

Scope

- Detailed information on Sanofi Genzyme required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Sanofi Genzyme in the form of a SWOT analysis
- An in-depth view of the business model of Sanofi Genzyme including a breakdown and examination of key business segments
- Intelligence on Sanofi Genzyme’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Sanofi Genzyme, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Sanofi Genzyme and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Sanofi Genzyme as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Sanofi Genzyme’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Table of Contents
Sanofi Genzyme: Company Overview
Sanofi Genzyme: Overview and Key Facts
Sanofi Genzyme: Overview
Sanofi Genzyme: Key Facts
Sanofi Genzyme: Key Employees
Sanofi Genzyme: Key Employee Biographies
Sanofi Genzyme: Major Products and Services
Sanofi Genzyme: Company History
Sanofi Genzyme: Locations and Subsidiaries
Sanofi Genzyme: Key Competitors
Sanofi Genzyme: Company Analysis
Sanofi Genzyme: Business Description
Sanofi Genzyme: SWOT Analysis
Sanofi Genzyme: SWOT Overview
Sanofi Genzyme: Strengths
Sanofi Genzyme: Weaknesses
Sanofi Genzyme: Opportunities
Sanofi Genzyme: Threats
Sanofi Genzyme: Corporate Financial Deals Activity
Sanofi Genzyme: Financial Deals Overview
Sanofi Genzyme: Targets and Partners
Sanofi Genzyme: Top Deals 2015 – 2019YTD*
Sanofi Genzyme: Mergers and Acquisitions
Sanofi Genzyme: Partnership
Sanofi Genzyme: Recent Developments
Sanofi Genzyme: News and Events Summary
Sanofi Genzyme: Contracts
Sanofi Genzyme: Market Developments
Sanofi Genzyme: Regulatory and Legal Events
Sanofi Genzyme: Research & Development
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: Sanofi Genzyme: Key Facts
Table 2: Sanofi Genzyme: Key Employees
Table 3: Sanofi Genzyme: Company History
Table 4: Sanofi Genzyme: Locations and Subsidiaries
Table 5: Sanofi Genzyme: Key Competitors
Table 6: Sanofi Genzyme: Deal Activity by Deal Type - Volume (TTM*)
Table 7: Sanofi Genzyme: Deal Activity by Deal Type - Volume (2015 - YTD*2019)
Table 8: Sanofi Genzyme: M&A Average Deal Size - Value (US$m)
Table 9: Sanofi Genzyme: Targets and Partners
Table 10: Sanofi Genzyme: Top Deals 2015 - 2019YTD*
Table 11: Sanofi Genzyme: M&A Volume and Value Trend (2015 - YTD*2019)
Table 12: Sanofi Genzyme: Partnership Volume and Value Trend (2015 - YTD*2019)
Table 13: Sanofi Genzyme: Partnership Trend by Deal Type (2015 - YTD*2019)
Table 14: Sanofi Genzyme: News and Events Summary
Table 15: Sanofi Genzyme: Contracts
Table 16: Sanofi Genzyme: Market Developments
Table 17: Sanofi Genzyme: Regulatory and Legal Events
Table 18: Sanofi Genzyme: Research & Development

★海外企業調査レポート[Sanofi Genzyme:企業の戦略・SWOT・財務分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • ALS Ltd (ALQ):企業の財務・戦略的SWOT分析
    ALS Ltd (ALQ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • ITC Holdings Corp.:発電所・企業SWOT分析
    ITC Holdings Corp. - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees …
  • North Eastern Electric Power Corporation Ltd:電力:M&Aディール及び事業提携情報
    Summary North Eastern Electric Power Corp Ltd (NEEPCO) is a government owned electric utility that generates, procures and sells electricity. The company designs, constructs, operates and maintains hydro, thermal and gas projects. NEEPCO generates electricity from hydro, thermal, and solar sources; …
  • Xcel Energy Inc:企業の発電所・SWOT分析2018
    Xcel Energy Inc - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (ex …
  • United Company RUSAL Plc:企業の戦略・SWOT・財務情報
    United Company RUSAL Plc - Strategy, SWOT and Corporate Finance Report Summary United Company RUSAL Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Sumitomo Realty & Development Co Ltd:戦略・SWOT・企業財務分析
    Sumitomo Realty & Development Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Sumitomo Realty & Development Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Salem Media Group, Inc. (SALM):企業の財務・戦略的SWOT分析
    Salem Media Group, Inc. (SALM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Herantis Pharma Plc (HRTIS):医療機器:M&Aディール及び事業提携情報
    Summary Herantis Pharma Plc (Herantis Pharma) is a drug development company that offers regenerative medicine for neurodegenerative diseases. The company's pipeline products include CDNF for amyotrophic lateral sclerosis, CDNF for Parkinson’s disease and lymfactin for secondary lymphedema. Its lymfa …
  • SPI Pharma Inc:企業の戦略的SWOT分析
    SPI Pharma Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Silver Bull Resources, Inc.:企業の戦略・SWOT・財務分析
    Silver Bull Resources, Inc. - Strategy, SWOT and Corporate Finance Report Summary Silver Bull Resources, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Fujita Kanko Inc:企業の戦略・SWOT・財務情報
    Fujita Kanko Inc - Strategy, SWOT and Corporate Finance Report Summary Fujita Kanko Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Eaton Corporation Plc (ETN):企業の財務・戦略的SWOT分析
    Eaton Corporation Plc (ETN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Flexible Solutions International Inc (FSI):企業の財務・戦略的SWOT分析
    Flexible Solutions International Inc (FSI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengt …
  • Medicines for Malaria Venture:企業のM&A・事業提携・投資動向
    Medicines for Malaria Venture - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Medicines for Malaria Venture Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and …
  • Live Nation Entertainment, Inc.:企業のM&A・事業提携・投資動向
    Live Nation Entertainment, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Live Nation Entertainment, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers …
  • LI-COR Inc-製薬・医療分野:企業M&A・提携分析
    Summary LI-COR Inc (LCB), doing business as LI-COR Biosciences is a medical device company that offers research services. The company offers scientific instruments for plant science research. It designs, manufactures and markets instruments, software, reagents, and integrated systems for biotechnolo …
  • Domestic & General Group Holdings Limited:企業の戦略・SWOT・財務情報
    Domestic & General Group Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Domestic & General Group Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SW …
  • Dr. Paul Lohmann GmbH KG:企業の戦略・SWOT・財務情報
    Dr. Paul Lohmann GmbH KG - Strategy, SWOT and Corporate Finance Report Summary Dr. Paul Lohmann GmbH KG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Twitter, Inc.:企業のM&A・事業提携・投資動向
    Twitter, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Twitter, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • Emcure Pharmaceuticals Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Emcure Pharmaceuticals Ltd (Emcure) develops, manufactures and markets a range of pharmaceutical products worldwide. The company specializes in the development and manufacture of differentiated pharmaceutical products. It also manufactures active pharmaceutical ingredients (APIs) primarily f …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆